Source: Therapeutics and clinical risk management. Unidade: FM
Subjects: BIÓPSIA, DISTROFIA MUSCULAR, NECROSE, IMUNOGLOBULINAS INTRAVENOSAS, NEOPLASIAS MAMÁRIAS
ABNT
CARVALHO, Alzira Alves de Siqueira e ZANOTELI, Edmar. Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report. Therapeutics and clinical risk management, v. 14, p. 903-907, 2018Tradução . . Disponível em: https://doi.org/10.2147/TCRM.S162931. Acesso em: 20 out. 2025.APA
Carvalho, A. A. de S., & Zanoteli, E. (2018). Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report. Therapeutics and clinical risk management, 14, 903-907. doi:10.2147/TCRM.S162931NLM
Carvalho AA de S, Zanoteli E. Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report [Internet]. Therapeutics and clinical risk management. 2018 ; 14 903-907.[citado 2025 out. 20 ] Available from: https://doi.org/10.2147/TCRM.S162931Vancouver
Carvalho AA de S, Zanoteli E. Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report [Internet]. Therapeutics and clinical risk management. 2018 ; 14 903-907.[citado 2025 out. 20 ] Available from: https://doi.org/10.2147/TCRM.S162931